IDF Premium courses

Management and Prevention of Cardio-Renal Complications in T2D

A blended learning programme of modules and webinars addressing the ongoing needs of any medical doctor involved in management of type 2 diabetes and prevention of cardio-renal complications.

uems

5 European CME credits (ECMEC)

4.9 (32)

Enrolled:

46 Learners

Views:

5226

IDF Premium courses

Select language

About this course

The purpose of the course is to enable the learner to understand about the latest evidence-based pharmaceutical management and early diagnosis, prevention of cardio-renal complications in type 2 diabetes.

Who is this course for?

General practitioners, primary care physicians, family physicians, and any medical doctor involved in management and prevention of cardio-renal complications in type 2 diabetes.

Curriculum

Initial Self-Evaluation

Complete your initial self-evaluation before starting the course module.

Learning Objectives:

At the end of this module the learner will be able to:

  • List the evidence-based clinical practice recommendations on prevention, diagnosis and management of T2D at primary care level
  • Discuss the recommendations on lifestyle and pharmacological management of T2D
  • Understand the management of T2D with complications, in special population, at-risk individuals and their referral
Learning Objectives

At the end of this module the learner will be able to:

  • Describe the pharmacology of glucose-lowering medications in diabetes
  • Describe the application of various glucose-lowering medications such as metformin, sulfonylureas, alpha-glucosidase inhibitors and thiazolidinediones in clinical practice
  • Discuss the guidelines-based approach in choosing glucose-lowering medications in the management of diabetes
Learning Objectives

At the end of this module the learner will be able to:

  • Discuss the pharmacology of oral glucose-lowering medications in diabetes
  • Describe the clinical application of various oral glucose-lowering medications including gliptins (dipeptidyl peptidase-4 inhibitor), glucagon-like peptide-1 (GLP-1) receptor agonist, sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice
  • Discuss guidelines-based approach in choosing oral glucose-lowering medications in the management of diabetes
Learning Objectives

At the end of this module the learner will be able to:

  • Discuss the overview of diabetes and cardiovascular diseasetes
  • Review the different types of cardiovascular complications
  • Describe the pathophysiology of cardiovascular complications in diabetes
  • Discuss the epidemiology of coronary heart disease, cerebrovascular disease and peripheral artery disease
  • List the potential risk factors associated with cardiovascular complications
  • Identify the screening and diagnostic tests for detecting cardiovascular complications in people with diabetes
  • Discuss the management strategies for cardiovascular complications
Learning Objectives

At the end of this module the learner will be able to:

  • Provide a brief overview of diabetic kidney disease
  • Discuss the global prevalence of diabetic kidney disease
  • Identify the potential risk factors associated with the development of diabetic kidney disease
  • Describe the pathophysiology of diabetic kidney disease.
  • Review the screening and diagnostic tests for detecting diabetic kidney disease
  • Discuss the guideline recommendations in the management of diabetic kidney disease


Complete your final self-evaluation to continue.

Please provide your feedback before continuing to print your certificate.

You can download and/or print your IDF Certificate.

coc courses
coc courses

How it works

Certificate

Course Certificate: Learners who complete all the course modules will receive an official IDF Certificate of Completion and five European CME credits.

Webinar Certificate: Learner’s will receive an official IDF Certificate of Attendance for each webinar.

Course Fees

The online course and webinars are supported by an education grant from

as part of AstraZeneca's TakeCareofMe programme

Learners Feedback

4.9

Average Rating

(32 ratings)
  • 91%
  • 8%
  • 1%
  • 0%
  • 0%
Course Details
Modules:

5

Webinars:

2

Course Duration:

9 hours

Approx. 12 weeks to complete

Language:

English

The online course and webinars are supported by an education grant from

Course Features

Self-paced flexible learning

Case studies

Live Webinars

Download course module

Certificate

European CME credits (ECMEC)

© 2022 - IDF - All Right Reserved | Privacy Policy 

Facebook
Twitter
Linkedin